Company Filing History:
Years Active: 2011-2014
Title: Frank C Bennett: Innovator in Respiratory Treatment and MicroRNA Detection
Introduction
Frank C Bennett is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the fields of respiratory treatment and microRNA detection. With a total of 2 patents, Bennett's work has the potential to impact medical practices and improve patient outcomes.
Latest Patents
Bennett's latest patents include innovative methods for treating respiratory conditions. One patent focuses on topical administrations of antisense compounds to VLA-4 for the treatment of respiratory diseases. This method involves administering a composition containing antisense compounds targeted to a nucleic acid molecule encoding integrin α4. The treatment aims to address conditions associated with airway hyperresponsiveness, eosinophilia, neutrophilia, leukocytes, or overproduction of mucus. Another patent pertains to microRNA detection, providing methods for detecting miRNA in a sample derived from a cell or tissue. This method employs a competitor molecule to facilitate the detection of miRNA in the presence of an anti-miRNA oligonucleotide.
Career Highlights
Throughout his career, Frank C Bennett has worked with various companies, including Antisense Therapeutics Limited and Regulus Therapeutics Inc. His expertise in the field has allowed him to develop groundbreaking technologies that address critical health issues.
Collaborations
Bennett has collaborated with notable individuals in his field, including George Tachas and James G Karras. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Frank C Bennett's contributions to respiratory treatment and microRNA detection highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing medical science and enhancing patient care.